Expression of FGFR1–4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity

Malignant pleural mesothelioma (MPM) is a devastating malignancy with limited therapeutic options. Fibroblast growth factor receptors (FGFR) and their ligands were shown to contribute to MPM aggressiveness and it was suggested that subgroups of MPM patients could benefit from FGFR-targeted inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Vlacic, Gregor, Hoda, Mir A., Klikovits, Thomas, Sinn, Katharina, Gschwandtner, Elisabeth, Mohorcic, Katja, Schelch, Karin, Pirker, Christine, Peter-Vörösmarty, Barbara, Brankovic, Jelena, Dome, Balazs, Laszlo, Viktoria, Cufer, Tanja, Rozman, Ales, Klepetko, Walter, Grasl-Kraupp, Bettina, Hegedus, Balazs, Berger, Walter, Kern, Izidor, Grusch, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769772/
https://www.ncbi.nlm.nih.gov/pubmed/31527449
http://dx.doi.org/10.3390/cells8091091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769772/
https://www.ncbi.nlm.nih.gov/pubmed/31527449
http://dx.doi.org/10.3390/cells8091091

Ejemplares similares